Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (IBSE: GENIL)
Health Care · Pharmaceuticals · TR
TL4.67
-11.89% today · -67.7% 1Y
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (IBSE: GENIL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $425.91M and employs 678 people.
Over the last twelve months the share price has lost 67.7%, trading between 3.49 and 14.93.
Tweenvest scores Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi across four factors: quality 63/100, value 70/100, growth 45/100, dividend 22/100. Its strongest factor is value.
GENIL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $425.91M
- Revenue (TTM)
- $475.11M
- P/E
- 21.67
- EPS
- 0.22
- Dividend yield
- 1.04%
- Beta (5Y)
- -0.03
- 52-week high
- TL14.93
- 52-week low
- TL3.49
- Avg volume (3M)
- —
- Shares outstanding
- 4.50B
- Employees
- 678
- Next earnings
- —
About Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. In addition, it manufactures, trades, imports and exports of all kinds of human medicines and health products. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
- ISIN
- TREGENL00024
- Founded
- 1997
- Listed since
- Aug 6, 2021
- Exchange
- Borsa Istanbul (BIST)
- Currency
- TRY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nika Pharmaceuticals, Inc.OTCPK: NIKA | $431.19M | $— | — |
| Guizhou Yibai Pharmaceutical Co., Ltd.SHSE: 600594 | $430.95M | CN¥3.68 | +1.10% |
| SMS Pharmaceuticals LimitedNSEI: SMSPHARMA | $430.28M | Rs444.65 | -5.65% |
| Anhui Fengyuan Pharmaceutical Co., Ltd.SZSE: 000153 | $427.35M | CN¥6.16 | +0.82% |
| Lumosa Therapeutics Co., Ltd.TPEX: 6535 | $425.85M | NT$81.30 | -4.35% |
| Gufic Biosciences LimitedBSE: 509079 | $419.45M | Rs404.80 | -3.20% |
| Renata PLCDSE: RENATA | $418.98M | Tk449.90 | +0.27% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,LtdSHSE: 600671 | $416.71M | CN¥22.92 | +5.19% |
Figures last refreshed Oct 11, 2026.